MDA Space Ltd. shares opened lower after the company revealed a large, discounted common stock offering to help finance the purchase of a controlling interest in Collecte Localisation Satellites (CLS). In morning trading the stock slipped 6.8% to $36.06, after the company announced both the equity sale and the CLS acquisition in close succession.
Shares began to decline in after-hours trading following the dual announcements that combined a bought deal equity financing with plans to buy roughly a 70% stake in CLS for approximately 567 million (C$920 million) in cash. Under the transaction terms, the French space agency CNES would retain the remaining roughly 30% interest.
The immediate downward pressure on the share price stems from the size and pricing of the equity offering and a subsequent upsizing. MDA Space initially agreed with a syndicate of underwriters led by BMO Capital Markets and RBC Capital Markets to sell 20 million common shares at $35.60 per share, for gross proceeds of $712 million. The company then amended the agreement to increase the size of the bought deal, with underwriters agreeing to purchase 23 million common shares at the same $35.60 price, producing aggregate gross proceeds of about $819 million.
The enlarged offering intensified concerns over shareholder dilution, extending the decline into regular trading hours. Investors reacted to the transaction structure even as MDA Space highlighted strategic benefits tied to the CLS acquisition. Management expects the deal to roughly double the company's recurring revenue base and to be accretive to Adjusted EBITDA and Adjusted EPS within the first year after closing.
Projected operational metrics for CLS played a role in the acquisition rationale. CLS's expected Adjusted EBITDA margins are said to be in line with MDA Space's 2026 full-year outlook of 18% to 20%. The company noted that the transaction is expected to close by the end of 2026 or in early 2027, subject to obtaining necessary regulatory approvals.
Despite those prospective financial synergies, the market reaction was governed by near-term capital structure implications. The equity issuance price represented a material discount to recent trading levels and the increase in the deal size magnified dilution fears, which in turn pushed the stock to a session low of $35.45, well below its 52-week high of $49.37.
It is important to note that the pressure on MDA Space appears company-specific. Broader U.S. equity benchmarks were trading higher during the same period - the S&P 500 gained about 0.5%, the Dow Jones rose 0.2%, and the Nasdaq climbed 0.6% - indicating that the decline in MDA Space was driven by the financing and acquisition announcements rather than a wider market selloff. There were no major competitor announcements identified as contributors to the move.
Takeaway - The combination of a sizable, discounted equity issuance announced after the market close and an upsizing the following morning created layering of dilution concerns that overwhelmed investor appetite for the strategic merits of acquiring CLS in the near term.